Several studies have linked the JAK/STAT pathway to amyloidosis and AD, and our molecular docking results showed that GS-Rd can interact directly with JAK2 and STAT3, suggesting that GS-Rd may exert anti-AD activity by regulating Aβ deposition through the modulation of the JAK/STAT pathway. The gene discussed is SOAT1; the disease is amyloidosis.